
Precision Medicine Podcast · Trapelo
New Legislation Helps Deliver Appropriate Biomarker Testing to More Cancer Patients When and Where They Need It
·38 min·2 clips
Hilary says 71% of people in the largest plan in each state were covered by policies more restrictive than NCCN guidelines.
As heard by us
Policy, testing, and coverage come together in a clear look at how precision medicine reaches patients.
Biomarker testing sits at the center of this episode, and the policy angle stays grounded in that reality. Karen Cushman keeps the discussion practical while Hilary G.
Why you'd press play
Want the policy behind better cancer testing, without the jargon pileup?
Listen to the show on